{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:39:15Z","timestamp":1788187155721,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04282-z","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:12:57Z","timestamp":1748527977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of inflammatory skin disorders in patients with inflammatory bowel disease (IBD)"],"prefix":"10.1007","volume":"317","author":[{"given":"Shahin","family":"Hamzelou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser Ebrahimi","family":"Daryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Farshad","family":"Allameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nasimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr Boroumand","family":"Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid Namakizadeh","family":"Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"4282_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","volume":"28","author":"A Kaser","year":"2010","unstructured":"Kaser A, Zeissig S, Blumberg RS (2010) Inflammatory bowel disease. Annu Rev Immunol 28:573\u2013621","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"4282_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/17474124.2019.1574569","volume":"13","author":"T Greuter","year":"2019","unstructured":"Greuter T, Vavricka SR (2019) Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol 13(4):307\u2013317","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"4282_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0889-8553(01)00002-4","volume":"31","author":"EV Loftus Jr","year":"2002","unstructured":"Loftus EV Jr., Sandborn WJ (2002) Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 31(1):1\u201320","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"4282_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142(1):46\u201354 e42; quiz e30","journal-title":"Gastroenterology"},{"issue":"2 Suppl","key":"4282_CR5","first-page":"140","volume":"38","author":"AR Safarpour","year":"2013","unstructured":"Safarpour AR, Hosseini SV, Mehrabani D (2013) Epidemiology of inflammatory bowel diseases in Iran and Asia; a mini review. Iran J Med Sci 38(2 Suppl):140\u2013149","journal-title":"Iran J Med Sci"},{"issue":"3","key":"4282_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.5217\/ir.2018.00157","volume":"17","author":"MM Malekzadeh","year":"2019","unstructured":"Malekzadeh MM et al (2019) Iranian registry of Crohn\u2019s and colitis: study profile of first nation-wide inflammatory bowel disease registry in middle East. Intest Res 17(3):330\u2013339","journal-title":"Intest Res"},{"issue":"12","key":"4282_CR7","first-page":"22529","volume":"8","author":"Y Ye","year":"2015","unstructured":"Ye Y et al (2015) The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med 8(12):22529\u201322542","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"4282_CR8","doi-asserted-by":"publisher","first-page":"e17184","DOI":"10.1371\/journal.pone.0017184","volume":"6","author":"JM Thomson","year":"2011","unstructured":"Thomson JM et al (2011) Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PLoS ONE 6(2):e17184","journal-title":"PLoS ONE"},{"issue":"1","key":"4282_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3748\/wjg.v21.i1.21","volume":"21","author":"GE Tontini","year":"2015","unstructured":"Tontini GE et al (2015) Differential diagnosis in inflammatory bowel disease colitis: state of the Art and future perspectives. World J Gastroenterol 21(1):21\u201346","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4282_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/ajg.2010.343","volume":"106","author":"SR Vavricka","year":"2011","unstructured":"Vavricka SR et al (2011) Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 106(1):110\u2013119","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4282_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/01.MIB.0000436959.62286.f9","volume":"20","author":"AV Marzano","year":"2014","unstructured":"Marzano AV et al (2014) Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis 20(1):213\u2013227","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"4282_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/ecco-jcc\/jjv232","volume":"10","author":"K Karmiris","year":"2016","unstructured":"Karmiris K et al (2016) Prevalence and characteristics of Extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohns Colitis 10(4):429\u2013436","journal-title":"J Crohns Colitis"},{"issue":"3","key":"4282_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12016-017-8617-4","volume":"53","author":"T Greuter","year":"2017","unstructured":"Greuter T, Navarini A, Vavricka SR (2017) Skin manifestations of inflammatory bowel disease. Clin Rev Allergy Immunol 53(3):413\u2013427","journal-title":"Clin Rev Allergy Immunol"},{"key":"4282_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fphys.2012.00013","volume":"3","author":"BL Huang","year":"2012","unstructured":"Huang BL, Chandra S, Shih DQ (2012) Skin manifestations of inflammatory bowel disease. Front Physiol 3:13","journal-title":"Front Physiol"},{"issue":"139","key":"4282_CR15","first-page":"225","volume":"25","author":"U Keyal","year":"2018","unstructured":"Keyal U, Liu Y, Bhatta AK (2018) Dermatologic manifestations of inflammatory bowel disease: a review. Discov Med 25(139):225\u2013233","journal-title":"Discov Med"},{"issue":"4","key":"4282_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ecco-jcc\/jjx178","volume":"12","author":"J Vide","year":"2018","unstructured":"Vide J et al (2018) Cutaneous morbidity among inflammatory bowel disease patients: A cohort study. J Crohns Colitis 12(4):442\u2013451","journal-title":"J Crohns Colitis"},{"issue":"3","key":"4282_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3109\/00365521.2014.991752","volume":"50","author":"R Isene","year":"2015","unstructured":"Isene R et al (2015) Extraintestinal manifestations in Crohn\u2019s disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol 50(3):300\u2013305","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"4282_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12016-012-8351-x","volume":"45","author":"AV Marzano","year":"2013","unstructured":"Marzano AV et al (2013) Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet\u2019s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 45(2):202\u2013210","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"4282_CR19","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","volume":"96","author":"CN Bernstein","year":"2001","unstructured":"Bernstein CN et al (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96(4):1116\u20131122","journal-title":"Am J Gastroenterol"},{"issue":"46","key":"4282_CR20","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","volume":"11","author":"S Danese","year":"2005","unstructured":"Danese S et al (2005) Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11(46):7227\u20137236","journal-title":"World J Gastroenterol"},{"key":"4282_CR21","doi-asserted-by":"crossref","unstructured":"Li Y et al (2022) Causal association between inflammatory bowel disease and psoriasis: a two-sample bidirectional Mendelian randomization study. Frontiers in Immunology 13","DOI":"10.3389\/fimmu.2022.916645"},{"issue":"14","key":"4282_CR22","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.3390\/ijms25147762","volume":"25","author":"K Pocino","year":"2024","unstructured":"Pocino K et al (2024) Tumor necrosis Factor-Alpha: ally and enemy in protean cutaneous sceneries. Int J Mol Sci 25(14):7762","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4282_CR23","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1097\/MIB.0000000000001260","volume":"23","author":"T Yoshihara","year":"2017","unstructured":"Yoshihara T et al (2017) Tissue drug concentrations of Anti-tumor necrosis factor agents are associated with the Long-term outcome of patients with Crohn\u2019s disease. Inflamm Bowel Dis 23(12):2172\u20132179","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"4282_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","volume":"63","author":"C Tillack","year":"2014","unstructured":"Tillack C et al (2014) Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-gamma-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment. Gut 63(4):567\u2013577","journal-title":"Gut"},{"issue":"2","key":"4282_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/2475530318810851","volume":"4","author":"SJ Li","year":"2019","unstructured":"Li SJ, Perez-Chada LM, Merola JF (2019) TNF Inhibitor-Induced psoriasis: proposed algorithm for treatment and management. J Psoriasis Psoriatic Arthritis 4(2):70\u201380","journal-title":"J Psoriasis Psoriatic Arthritis"},{"issue":"4","key":"4282_CR26","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/MIB.0000000000000757","volume":"22","author":"I Guerra","year":"2016","unstructured":"Guerra I et al (2016) Incidence, clinical characteristics, and management of psoriasis induced by Anti-TNF therapy in patients with inflammatory bowel disease: A nationwide cohort study. Inflamm Bowel Dis 22(4):894\u2013901","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"4282_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3109\/00365521.2015.1125524","volume":"51","author":"AE Hellstrom","year":"2016","unstructured":"Hellstrom AE, Farkkila M, Kolho KL (2016) Infliximab-induced skin manifestations in patients with inflammatory bowel disease. Scand J Gastroenterol 51(5):563\u2013571","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"4282_CR28","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/j.1365-2133.2009.09329.x","volume":"161","author":"J Seneschal","year":"2009","unstructured":"Seneschal J et al (2009) Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 161(5):1081\u20131088","journal-title":"Br J Dermatol"},{"issue":"3","key":"4282_CR29","first-page":"252","volume":"90","author":"A Mebazaa","year":"2012","unstructured":"Mebazaa A et al (2012) Dermatologic manifestations in inflammatory bowel disease in Tunisia. Tunis Med 90(3):252\u2013257","journal-title":"Tunis Med"},{"issue":"2","key":"4282_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/MPG.0b013e318093f4b0","volume":"46","author":"FA Jose","year":"2008","unstructured":"Jose FA, Heyman MB (2008) Extraintestinal manifestations of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 46(2):124\u2013133","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"46","key":"4282_CR31","doi-asserted-by":"publisher","first-page":"17463","DOI":"10.3748\/wjg.v20.i46.17463","volume":"20","author":"M Zippi","year":"2014","unstructured":"Zippi M et al (2014) Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 20(46):17463\u201317467","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4282_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.4103\/0378-6323.45102","volume":"74","author":"H Moravvej","year":"2008","unstructured":"Moravvej H et al (2008) Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study. Indian J Dermatol Venereol Leprol 74(6):607\u2013610","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"6","key":"4282_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2310\/7750.2014.13209","volume":"18","author":"F Topaloglu Demir","year":"2014","unstructured":"Topaloglu Demir F et al (2014) Mucocutaneous manifestations of inflammatory bowel disease in Turkey. J Cutan Med Surg 18(6):397\u2013404","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"4282_CR34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","volume":"143","author":"MD Long","year":"2012","unstructured":"Long MD et al (2012) Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology 143(2):390\u2013399e1","journal-title":"Gastroenterology"},{"issue":"5","key":"4282_CR35","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","volume":"141","author":"L Peyrin-Biroulet","year":"2011","unstructured":"Peyrin-Biroulet L et al (2011) Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology 141(5):1621\u201328e1","journal-title":"Gastroenterology"},{"issue":"7","key":"4282_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamadermatol.2020.1300","volume":"156","author":"S Esse","year":"2020","unstructured":"Esse S et al (2020) Melanoma risk in patients treated with biologic therapy for common inflammatory diseases: A systematic review and Meta-analysis. JAMA Dermatol 156(7):787\u2013794","journal-title":"JAMA Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04282-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04282-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04282-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:12:59Z","timestamp":1748527979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04282-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4282"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04282-z","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"786"}}